Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Epothilone B effective and well tolerated in advanced breast cancer

Dec. 30, 2002

Clinical results reported for lonafarnib in hematological malignancies

Dec. 30, 2002

Efficacy and safety of tipifarnib in leukemia and other hematological disorders

Dec. 30, 2002

Prinomastat monotherapy in low-risk myelodysplastic syndrome

Dec. 30, 2002

New data on the HDAC inhibitor MS-275 in leukemia

Dec. 30, 2002

Decalactones of fungal origin reported to exhibit antitumor and antiinfective activity

Dec. 27, 2002

CP-461 well tolerated in a phase I trial in patients with advanced cancer

Dec. 27, 2002

Arzoxifene and LG-100268 effective alone and in combination in a rat breast cancer model

Dec. 27, 2002

SN-38 induces cell cycle arrest and apoptosis in human testicular cancer cells

Dec. 27, 2002

Internal analysis of European cetuximab colorectal cancer trial data at Merck KGaA

Dec. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...